Showing posts with label rheumatoid arthritis. Show all posts
Showing posts with label rheumatoid arthritis. Show all posts
Wednesday, 30 October 2019
What is rheumatoid arthritis?
Monday, 21 December 2015
Dr Jim Harris receives Abbvie grant to study mechanisms of rheumatoid arthritis
 |
| Dr Jim Harris |
Congratulations
Dr Jim Harris who has received a grant of $48,500 from pharmaceutical company
Abbvie for his study “Autophagy in rheumatoid arthritis: effects of TNF
blockade”.
Chief
Investigator in the Lupus and Arthritis lab, Centre for Inflammatory Diseases,
Dr Harris will study autophagy in cells from patients with rheumatoid arthritis.
“In
this study we will look at the effect of TNF blockers, a common treatment for
rheumatoid arthritis (RA) on autophagy, a cellular process involved in numerous
immune cell functions,” said Dr Harris.
In
addition, Dr Harris’ group will investigate autophagic responses in cells from
patients with RA, to determine whether defects in this process might account
for some of the inflammatory pathology in these patients.
“This
is a chance for us to utilise our close connection to the rheumatology clinic
and test important regulatory mechanisms in cells from patients with RA.”
Tuesday, 24 February 2015
Foundation grant awarded to further rheumatology research
 |
| Dr Jim Harris |
Congratulations Dr Jim Harris who has received a competitive Rebecca
L. Cooper Medical Research Foundation grant.
The Foundation Grant worth $22,000 will be used towards a new piece
of equipment, a Direct Detect Spectrometer from Millipore.
The Rebecca L Cooper Medical Research
Foundation directs funds towards high quality research and high quality
researchers to support the direct costs of research, typically tangibles
including laboratory equipment and consumables.
“We’re really pleased with the outcome as this is the first time
we’ve applied for one of these grants,” said Chief Investigator Dr Harris.
Dr Sarah Jones and Professor Eric Morand are co-investigators on
the grant proposal, "New Therapeutic Targets in Rheumatological
Diseases".
“The new equipment will allow us to measure protein levels in
biological samples, including clinical samples, serum, etc. much more quickly
and efficiently than previously,” added Dr Harris.
The machine will be used in the laboratory’s study of
rheumatological diseases, including lupus and rheumatoid arthritis.
Subscribe to:
Posts (Atom)